Mark E. Boulding
2019
In 2019, Mark E. Boulding earned a total compensation of $2.5M as Executive Vice President and Chief Legal Officer at PTC Therapeutics, a 56% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $237,500 |
|---|---|
| Option Awards | $1,776,569 |
| Salary | $475,000 |
| Other | $20,925 |
| Total | $2,509,994 |
Boulding received $1.8M in option awards, accounting for 71% of the total pay in 2019.
Boulding also received $237.5K in non-equity incentive plan, $475K in salary and $20.9K in other compensation.
Rankings
In 2019, Mark E. Boulding's compensation ranked 4,841st out of 13,971 executives tracked by ExecPay. In other words, Boulding earned more than 65.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,841 out of 13,971 | 65th |
Division Manufacturing | 1,807 out of 5,695 | 68th |
Major group Chemicals And Allied Products | 629 out of 2,194 | 71st |
Industry group Drugs | 529 out of 1,880 | 72nd |
Industry Pharmaceutical Preparations | 396 out of 1,392 | 72nd |
Source: SEC filing on April 29, 2021.
Boulding's colleagues
We found four more compensation records of executives who worked with Mark E. Boulding at PTC Therapeutics in 2019.